Cargando…

Lutetium-177 Dotatate-Induced Hemolytic Anemia and Myelodysplastic Syndrome

Lutetium-177 ((177)Lu) dotatate is a type of peptide receptor radioligand therapy (PRRT) using radiolabeled somatostatin for patients with progressive somatostatin receptor-positive gastrointestinal neuroendocrine tumors. While cases of therapy-related myeloid neoplasms (t-MN) have been described as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alkassis, Samer, Ali, Mohammed, Awadelkarim, Abdalaziz M, Saad, Eltaib, Halboni, Adnan, Alhusain, Rashid, Kamatham, Saivaishnavi, Idris, Isra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938243/ https://www.ncbi.nlm.nih.gov/pubmed/35371754 http://dx.doi.org/10.7759/cureus.22392

Ejemplares similares

Lutetium Lu-177 Dotatate Flare Reaction
por: Salner, Andrew L., et al.
Publicado: (2020)

Lutetium-177 DOTATATE Production with an Automated Radiopharmaceutical Synthesis System
por: Aslani, Alireza, et al.
Publicado: (2015)

SHDB mutant functional metastatic paraganglioma: The efficacy of Lutetium-177 DOTATE
por: Erturk, Banu, et al.
Publicado: (2023)

Early Hyporegenerative Anemia Complicating Hemolytic Disease of the Newborn Secondary to Rhesus Alloimmunization
por: Acosta, Catalina, et al.
Publicado: (2021)

The Ominous Triad of Severe Takotsubo Cardiomyopathy
por: Awadelkarim, Abdalaziz, et al.
Publicado: (2022)

Daptomycin-Associated Diarrhea: A Case Report and Review of the Literature
por: Awadelkarim, Abdalaziz M, et al.
Publicado: (2022)

(177)Lutetium-Dotatate delays decline in quality of life in patients with midgut neuroendocrine tumors
por: Strosberg, Jonathan
Publicado: (2018)

Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma
por: Gubbi, Sriram, et al.
Publicado: (2021)

Incomplete Kawasaki Disease in an Infant: A Case Report and Literature Review
por: Idris, Isra, et al.
Publicado: (2022)

The Diagnostic Dilemma of Acute Granulomatous Hepatitis in a Patient With Crohn’s Disease: A Case Report and Review of Literature
por: Saad, Eltaib, et al.
Publicado: (2022)

Software-assisted dosimetry in peptide receptor radionuclide therapy with (177)Lutetium-DOTATATE for various imaging scenarios
por: Kupitz, Dennis, et al.
Publicado: (2017)

New Phenotypic Feature in a Patient With a Rare Triplication of the 22q11.2 Region Presenting With Peters Anomaly, Congenital Heart Disease, and Global Developmental Delay: A Case Report and Literature Review
por: Idris, Isra, et al.
Publicado: (2022)

Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Presenting as Recurrent Ischemic Stroke: The Microthrombi Shower
por: Dayco, John, et al.
Publicado: (2022)

MON-214 Biochemical Abnormalities in Endocrine Function Associated with Lutetium 177-DOTATATE Therapy in Metastatic Pheochromocytoma and Paraganglioma
por: Gubbi, Sriram, et al.
Publicado: (2020)

RISK FACTORS AND THE PROGNOSTIC SIGNIFICANCE OF COVID 19 INDUCED BRADYARRHYTHMIA: A SINGLE CENTER RETROSPECTIVE COHORT ANALYSIS.
por: Awadelkarim, Abdalaziz, et al.
Publicado: (2023)

Lutetium oxodotreotide ((177)Lu-Dotatate) for the treatment of unresectable or metastatic progressive gastroenteropancreatic neuroendocrine tumors: a cost-effectiveness analysis for Scotland
por: Smith-Palmer, J., et al.
Publicado: (2021)

Challenges and future options for the production of lutetium-177
por: Vogel, W. V., et al.
Publicado: (2021)

Thoracic Spinal Cord Compression Secondary to Metastatic Papillary Thyroid Carcinoma: An Unusual Oncological Phenomenon
por: Saad, Eltaib A, et al.
Publicado: (2022)

Definitive Treatment of Brain Metastases From a Neuroendocrine Tumor With Peptide Receptor Radionuclide Therapy With 177Lutetium DOTATATE: A Case Report
por: Zhang, Vivian, et al.
Publicado: (2023)

Inter-comparison of quantitative imaging of lutetium-177 ((177)Lu) in European hospitals
por: Wevrett, Jill, et al.
Publicado: (2018)

SAT-502 Clinical Hypothyroidism Associated with Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma: A Novel Adverse Effect of Peptide Receptor Radionuclide Therapy
por: Gubbi, Sriram, et al.
Publicado: (2020)

Lutetium-177-PSMA-617: A Vision of the Future
por: Chandran, Elias, et al.
Publicado: (2022)

Lutetium Lu 177 Vipivotide Tetraxetan: First Approval
por: Keam, Susan J.
Publicado: (2022)

Safety and Therapeutic Optimization of Lutetium-177 Based Radiopharmaceuticals
por: Ladrière, Typhanie, et al.
Publicado: (2023)

D-53 | Impact of Cardiovascular Diseases, Calcium Channel Blockers and Beta-Blockers on Mortality of Patients Hospitalized with COVID-19
por: Alhusain, Rashid, et al.
Publicado: (2022)

Turnpike Catheter failure, causes and mechanisms: Insights from the MAUDE database
por: Alhusain, Rashid, et al.
Publicado: (2022)

TCT-548 Impact of Cardiovascular Diseases, Calcium-Channel Blockers, and Beta-Blockers on Two-Year Mortality of Patients With COVID-19: A Single-Center Retrospective Analysis
por: Alhusain, Rashid, et al.
Publicado: (2022)

BRADYCARDIC PAUSES INDUCED BY MECHANICAL ECMO CANNULA STIMULATION OF THE CAROTID SINUS IN A PATIENT WITH SEVERE COVID-19
por: Dayco, John, et al.
Publicado: (2023)

Neuroendocrine Tumor Therapy with Lutetium-177: A Literature Review
por: Maqsood, Muhammad Haisum, et al.
Publicado: (2019)

Extensive Aortic Thrombosis and Renal Infarction in Association With an Active Flare-Up of Crohn’s Disease
por: Saad, Eltaib, et al.
Publicado: (2022)

Tocilizumab-Associated Small Bowel Perforation in a Young Patient With Rheumatoid Arthritis: A Lesson to Remember During COVID-19 Pandemic
por: Saad, Eltaib, et al.
Publicado: (2022)

Imaging and treatment with (68)Gallium and (177)Lutetium-DOTATATE in a rare SSTR2 and ESWR1-CREM fusion positive undifferentiated round cell tumour of the lung
por: Kumaran, Arjunan, et al.
Publicado: (2022)

Lutetium DOTATATE whole body scans: A novel approach for evaluation of neuroendocrine tumors
por: Singh, Natasha, et al.
Publicado: (2011)

Leuprolide-Induced Hyperosmolar Hyperglycemic State in an Elderly Patient: A Case Report and Literature Review
por: Saad, Eltaib, et al.
Publicado: (2022)

(177)Lutetium SPECT/CT: Evaluation of collimator, photopeak and scatter correction
por: Huizing, Daphne M. V., et al.
Publicado: (2020)

Clinical Best Practices for Radiation Safety During Lutetium-177 Therapy
por: Cappon, Derek John, et al.
Publicado: (2023)

Image Findings of a Rare Case of Neuroendocrine Tumor Metastatic to Orbital Extraocular Muscle in Gallium-68 DOTANOC Positron Emission Tomography/Computed Tomography and Therapy with Lutetium-177 DOTATATE
por: Kamaleshwaran, Koramadai Karuppusamy, et al.
Publicado: (2017)

A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of (177)Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma–LuDO-N
por: Sundquist, Fredrik, et al.
Publicado: (2022)

Survival and Response Outcomes for Gastrointestinal Neuroendocrine Tumor (GEP-NETs) Patients Treated with Lutetium—177-DOTATATE in a Brazilian Reference Center: A Six-Year Follow-Up Experience
por: de Souza, Zenaide Silva, et al.
Publicado: (2023)

Omental Fat Torsion: A Rare Mimicker of a Common Condition
por: Saad, Eltaib, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0t6ogsjv44i9fprop1hsl6uaqd